Parameters | Treatment failure (n = 22) | No evidence of disease (n = 50) | P value |
---|---|---|---|
Age (year) | 55.7 ± 16.0 | 56.0 ± 14.1 | 0.947 |
Tumor site (R:L) | 8:14 | 24:26 | 0.360 |
HPV status | Â | Â | 0.381 |
 Positive | 4 | 6 |  |
 Negative | 4 | 17 |  |
T stage | Â | Â | 0.019* |
 1/2 | 10 | 37 |  |
 3/4 | 12 | 13 |  |
N stage | Â | Â | 0.341 |
 0 | 11 | 31 |  |
 1/2 | 11 | 19 |  |
TNM stage | Â | Â | 0.201 |
 I/II | 7 | 24 |  |
 III/IVA | 15 | 26 |  |
Lymphatic invasion | Â | Â | 0.005* |
 No | 11 | 41 |  |
 Yes | 11 | 9 |  |
Venous invasion | Â | Â | 0.012* |
 No | 16 | 47 |  |
 Yes | 6 | 3 |  |
Perineural invasion | Â | Â | 0.008* |
 No | 12 | 42 |  |
 Yes | 10 | 8 |  |
Adjuvant therapy | Â | Â | 0.113 |
 No | 7 | 26 |  |
 RT/CCRT | 15 | 24 |  |